Advanced Chemotherapy Technologies: Funding & Investors (Oct 2026)
Advanced Chemotherapy Technologies is a healthcare company that is developing breakthrough combination drug-device technologies for treating pancreatic cancer.
Advanced Chemotherapy Technologies has raised $6.5M across 2 funding rounds on record, the most recent a Grant of $4.0M announced in Aug 2021.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Advanced Chemotherapy Technologies Company Profile and Key Stats
Latest funding round on record: Aug 2021.
Advanced Chemotherapy Technologies Funding Rounds
Advanced Chemotherapy Technologies raised $2.5M in a Series A announced in Feb 2021.
6 months later, a Grant of $4.0M was announced in Aug 2021.
Advanced Chemotherapy Technologies Founders and Leadership Team
No contact details are on record for this team yet.
Advanced Chemotherapy Technologies Funding Compared to Other Health Care Startups
Advanced Chemotherapy Technologies' latest round of $4.0M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Advanced Chemotherapy Technologies in Health Care and Raleigh
Companies Similar to Advanced Chemotherapy Technologies
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Advanced Chemotherapy Technologies Funding FAQs
What does Advanced Chemotherapy Technologies do?
Advanced Chemotherapy Technologies is a healthcare company that is developing breakthrough combination drug-device technologies for treating pancreatic cancer.
How much funding has Advanced Chemotherapy Technologies raised?
Advanced Chemotherapy Technologies has raised $6.5M across 2 rounds on record. The most recent is a Grant of $4.0M announced in Aug 2021.
When did Advanced Chemotherapy Technologies last raise funding?
Advanced Chemotherapy Technologies' most recent funding round on record is a Grant of $4.0M, announced in Aug 2021.
Who is the CEO of Advanced Chemotherapy Technologies?
Tony Voiers is listed as CEO at Advanced Chemotherapy Technologies.
Where is Advanced Chemotherapy Technologies headquartered?
Advanced Chemotherapy Technologies is based in Raleigh, North Carolina, United States.
How many employees does Advanced Chemotherapy Technologies have?
Advanced Chemotherapy Technologies is in the 1-10 employee band.
How does Advanced Chemotherapy Technologies' funding compare to other Health Care startups?
Advanced Chemotherapy Technologies' latest round of $4.0M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Advanced Chemotherapy Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Advanced Chemotherapy Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.